Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards MarketBRISBANE, Australia and CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Australian biotechnology company Vaxxas Pty Ltd, today announced the appointment of Mr Brent MacGregor as Independent Non-Executive Director to the Vaxxas Board. Mr MacGregor brings deep global experience in vaccine and medical device commercialisation to Vaxxas as the company advances its high-density microarray patch (HD-MAP) technology for self-administered vaccination towards market.
Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technologyBRISBANE, Australia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd, the biotechnology company pioneering the high-density microarray patch (HD-MAP) for needle-free vaccine delivery, today announced that it has secured ~$90 million in its latest financing round.
